Advertisement

Topics

Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike

07:25 EDT 19 Jul 2018 | Xconomy

Nearly one year ago, biotech startup IFM Therapeutics sold some of its assets to Bristol-Myers Squibb for $300 million. But IFM’s founders stuck around to try to capitalize on the startup’s remaining research. They’ve formed a Boston business, IFM Tre, that has just raised $31 million to fund some of that work. The cash comes […]

Original Article: Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike

NEXT ARTICLE

More From BioPortfolio on "Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...